ESC Premium Access

Percutaneous left atrial appendage closure versus novel anticoagulation agents in high-risk atrial fibrillation patients (PRAGUE-17 study)

Congress Presentation

About the speaker

Doctor Pavel Osmancik

Charles University of Prague, Prague (Czechia)
1 presentation
0 follower

4 more presentations in this session

Immediate versus Delayed Stenting After Primary Percutaneous Reperfusion in ST-Elevation Myocardial Infarction: The PRIMACY Bayesian Randomized Controlled Trial

Speaker: Doctor M. Jolicoeur (Montreal, CA)


Ultrathin-strut biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in acute myocardial infarction: a randomized controlled trial

Speaker: Doctor J. Iglesias (Geneva, CH)


Low-dose rivaroxaban after left atrial appendage closure: The randomized ADRIFT study

Speaker: Professor G. Montalescot (Paris, FR)


Randomized, Multicenter Comparison of Intensified versus Standard Loading Strategies with P2Y12-Receptor-Inhibitors in Patients Undergoing Elective PCI

Speaker: Professor J. Mehilli (Landshut, DE)


Access the full session

Late Breaking Science in Intervention

Speakers: Doctor P. Osmancik, Doctor M. Jolicoeur, Doctor J. Iglesias, Professor G. Montalescot, Professor J. Mehilli

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb